Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
7.67
+0.24 (3.23%)
At close: Nov 26, 2025, 4:00 PM EST
7.56
-0.11 (-1.43%)
After-hours: Nov 26, 2025, 6:14 PM EST
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 12 analysts that cover Wave Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $19.08, which forecasts a 148.76% increase in the stock price over the next year. The lowest target is $10 and the highest is $26.
Price Target: $19.08 (+148.76%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 8 | 8 | 6 |
| Buy | 7 | 8 | 8 | 8 | 8 | 6 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 15 | 16 | 17 | 17 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +160.76% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +108.60% | Nov 11, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +186.83% | Oct 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +134.68% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +186.83% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
47.41M
from 108.30M
Decreased by -56.22%
Revenue Next Year
50.37M
from 47.41M
Increased by 6.24%
EPS This Year
-1.17
from -0.70
EPS Next Year
-1.20
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 89.3M | 106.1M | |||
| Avg | 47.4M | 50.4M | |||
| Low | 17.5M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -17.6% | 123.7% | |||
| Avg | -56.2% | 6.2% | |||
| Low | -83.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.97 | -0.79 | |||
| Avg | -1.17 | -1.20 | |||
| Low | -1.39 | -1.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.